Cargando…

Structural and functional brain alterations in patients with myasthenia gravis

Myasthenia gravis is an autoimmune disease affecting neuromuscular transmission and causing skeletal muscle weakness. Additionally, systemic inflammation, cognitive deficits and autonomic dysfunction have been described. However, little is known about myasthenia gravis-related reorganization of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Klaus, Benita, Müller, Patrick, van Wickeren, Nora, Dordevic, Milos, Schmicker, Marlen, Zdunczyk, Yael, Brigadski, Tanja, Leßmann, Volkmar, Vielhaber, Stefan, Schreiber, Stefanie, Müller, Notger G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856136/
https://www.ncbi.nlm.nih.gov/pubmed/35198977
http://dx.doi.org/10.1093/braincomms/fcac018
_version_ 1784653780371898368
author Klaus, Benita
Müller, Patrick
van Wickeren, Nora
Dordevic, Milos
Schmicker, Marlen
Zdunczyk, Yael
Brigadski, Tanja
Leßmann, Volkmar
Vielhaber, Stefan
Schreiber, Stefanie
Müller, Notger G.
author_facet Klaus, Benita
Müller, Patrick
van Wickeren, Nora
Dordevic, Milos
Schmicker, Marlen
Zdunczyk, Yael
Brigadski, Tanja
Leßmann, Volkmar
Vielhaber, Stefan
Schreiber, Stefanie
Müller, Notger G.
author_sort Klaus, Benita
collection PubMed
description Myasthenia gravis is an autoimmune disease affecting neuromuscular transmission and causing skeletal muscle weakness. Additionally, systemic inflammation, cognitive deficits and autonomic dysfunction have been described. However, little is known about myasthenia gravis-related reorganization of the brain. In this study, we thus investigated the structural and functional brain changes in myasthenia gravis patients. Eleven myasthenia gravis patients (age: 70.64 ± 9.27; 11 males) were compared to age-, sex- and education-matched healthy controls (age: 70.18 ± 8.98; 11 males). Most of the patients (n = 10, 0.91%) received cholinesterase inhibitors. Structural brain changes were determined by applying voxel-based morphometry using high-resolution T(1)-weighted sequences. Functional brain changes were assessed with a neuropsychological test battery (including attention, memory and executive functions), a spatial orientation task and brain-derived neurotrophic factor blood levels. Myasthenia gravis patients showed significant grey matter volume reductions in the cingulate gyrus, in the inferior parietal lobe and in the fusiform gyrus. Furthermore, myasthenia gravis patients showed significantly lower performance in executive functions, working memory (Spatial Span, P = 0.034, d = 1.466), verbal episodic memory (P = 0.003, d = 1.468) and somatosensory-related spatial orientation (Triangle Completion Test, P = 0.003, d = 1.200). Additionally, serum brain-derived neurotrophic factor levels were significantly higher in myasthenia gravis patients (P = 0.001, d = 2.040). Our results indicate that myasthenia gravis is associated with structural and functional brain alterations. Especially the grey matter volume changes in the cingulate gyrus and the inferior parietal lobe could be associated with cognitive deficits in memory and executive functions. Furthermore, deficits in somatosensory-related spatial orientation could be associated with the lower volumes in the inferior parietal lobe. Future research is needed to replicate these findings independently in a larger sample and to investigate the underlying mechanisms in more detail.
format Online
Article
Text
id pubmed-8856136
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-88561362022-02-22 Structural and functional brain alterations in patients with myasthenia gravis Klaus, Benita Müller, Patrick van Wickeren, Nora Dordevic, Milos Schmicker, Marlen Zdunczyk, Yael Brigadski, Tanja Leßmann, Volkmar Vielhaber, Stefan Schreiber, Stefanie Müller, Notger G. Brain Commun Original Article Myasthenia gravis is an autoimmune disease affecting neuromuscular transmission and causing skeletal muscle weakness. Additionally, systemic inflammation, cognitive deficits and autonomic dysfunction have been described. However, little is known about myasthenia gravis-related reorganization of the brain. In this study, we thus investigated the structural and functional brain changes in myasthenia gravis patients. Eleven myasthenia gravis patients (age: 70.64 ± 9.27; 11 males) were compared to age-, sex- and education-matched healthy controls (age: 70.18 ± 8.98; 11 males). Most of the patients (n = 10, 0.91%) received cholinesterase inhibitors. Structural brain changes were determined by applying voxel-based morphometry using high-resolution T(1)-weighted sequences. Functional brain changes were assessed with a neuropsychological test battery (including attention, memory and executive functions), a spatial orientation task and brain-derived neurotrophic factor blood levels. Myasthenia gravis patients showed significant grey matter volume reductions in the cingulate gyrus, in the inferior parietal lobe and in the fusiform gyrus. Furthermore, myasthenia gravis patients showed significantly lower performance in executive functions, working memory (Spatial Span, P = 0.034, d = 1.466), verbal episodic memory (P = 0.003, d = 1.468) and somatosensory-related spatial orientation (Triangle Completion Test, P = 0.003, d = 1.200). Additionally, serum brain-derived neurotrophic factor levels were significantly higher in myasthenia gravis patients (P = 0.001, d = 2.040). Our results indicate that myasthenia gravis is associated with structural and functional brain alterations. Especially the grey matter volume changes in the cingulate gyrus and the inferior parietal lobe could be associated with cognitive deficits in memory and executive functions. Furthermore, deficits in somatosensory-related spatial orientation could be associated with the lower volumes in the inferior parietal lobe. Future research is needed to replicate these findings independently in a larger sample and to investigate the underlying mechanisms in more detail. Oxford University Press 2022-02-01 /pmc/articles/PMC8856136/ /pubmed/35198977 http://dx.doi.org/10.1093/braincomms/fcac018 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Guarantors of Brain. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Klaus, Benita
Müller, Patrick
van Wickeren, Nora
Dordevic, Milos
Schmicker, Marlen
Zdunczyk, Yael
Brigadski, Tanja
Leßmann, Volkmar
Vielhaber, Stefan
Schreiber, Stefanie
Müller, Notger G.
Structural and functional brain alterations in patients with myasthenia gravis
title Structural and functional brain alterations in patients with myasthenia gravis
title_full Structural and functional brain alterations in patients with myasthenia gravis
title_fullStr Structural and functional brain alterations in patients with myasthenia gravis
title_full_unstemmed Structural and functional brain alterations in patients with myasthenia gravis
title_short Structural and functional brain alterations in patients with myasthenia gravis
title_sort structural and functional brain alterations in patients with myasthenia gravis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856136/
https://www.ncbi.nlm.nih.gov/pubmed/35198977
http://dx.doi.org/10.1093/braincomms/fcac018
work_keys_str_mv AT klausbenita structuralandfunctionalbrainalterationsinpatientswithmyastheniagravis
AT mullerpatrick structuralandfunctionalbrainalterationsinpatientswithmyastheniagravis
AT vanwickerennora structuralandfunctionalbrainalterationsinpatientswithmyastheniagravis
AT dordevicmilos structuralandfunctionalbrainalterationsinpatientswithmyastheniagravis
AT schmickermarlen structuralandfunctionalbrainalterationsinpatientswithmyastheniagravis
AT zdunczykyael structuralandfunctionalbrainalterationsinpatientswithmyastheniagravis
AT brigadskitanja structuralandfunctionalbrainalterationsinpatientswithmyastheniagravis
AT leßmannvolkmar structuralandfunctionalbrainalterationsinpatientswithmyastheniagravis
AT vielhaberstefan structuralandfunctionalbrainalterationsinpatientswithmyastheniagravis
AT schreiberstefanie structuralandfunctionalbrainalterationsinpatientswithmyastheniagravis
AT mullernotgerg structuralandfunctionalbrainalterationsinpatientswithmyastheniagravis